Zhide Guo

3.4k total citations
99 papers, 2.8k citations indexed

About

Zhide Guo is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Zhide Guo has authored 99 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 39 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Molecular Biology. Recurrent topics in Zhide Guo's work include Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (25 papers) and Nanoplatforms for cancer theranostics (16 papers). Zhide Guo is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (25 papers) and Nanoplatforms for cancer theranostics (16 papers). Zhide Guo collaborates with scholars based in China, Singapore and United States. Zhide Guo's co-authors include Xianzhong Zhang, Rongqiang Zhuang, Changrong Shi, Gang Liu, Nanfeng Zheng, Xiaoyuan Chen, Xiaohong Chen, Mei Chen, Shiguang Mo and Xuejun Wen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Zhide Guo

94 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhide Guo China 26 1.2k 787 735 664 600 99 2.8k
Wiltrud Lederle Germany 30 1.4k 1.2× 610 0.8× 784 1.1× 552 0.8× 351 0.6× 63 3.1k
Zhanhong Wu United States 29 664 0.6× 687 0.9× 855 1.2× 980 1.5× 473 0.8× 79 3.1k
Christopher G. England United States 31 1.2k 1.0× 707 0.9× 1.3k 1.7× 762 1.1× 469 0.8× 50 3.3k
Sophie Hernot Belgium 26 1.3k 1.1× 612 0.8× 1.3k 1.8× 1.4k 2.1× 447 0.7× 78 3.6k
Vasileios Askoxylakis Germany 25 854 0.7× 754 1.0× 735 1.0× 477 0.7× 335 0.6× 49 2.5k
Reinier Hernandez United States 31 857 0.7× 688 0.9× 548 0.7× 1.2k 1.8× 605 1.0× 100 2.9k
Daniel L.J. Thorek United States 35 1.3k 1.1× 692 0.9× 1.2k 1.6× 1.2k 1.8× 646 1.1× 106 4.4k
Jason M. Warram United States 32 1.8k 1.5× 549 0.7× 611 0.8× 692 1.0× 363 0.6× 91 3.2k
Emily B. Ehlerding United States 33 1.7k 1.4× 763 1.0× 969 1.3× 895 1.3× 1.0k 1.7× 58 3.8k
Aron Popovtzer Israel 28 823 0.7× 520 0.7× 467 0.6× 483 0.7× 307 0.5× 134 2.9k

Countries citing papers authored by Zhide Guo

Since Specialization
Citations

This map shows the geographic impact of Zhide Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhide Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhide Guo more than expected).

Fields of papers citing papers by Zhide Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhide Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhide Guo. The network helps show where Zhide Guo may publish in the future.

Co-authorship network of co-authors of Zhide Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhide Guo. A scholar is included among the top collaborators of Zhide Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhide Guo. Zhide Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huifeng, Dongsheng Xia, Lingxin Meng, et al.. (2025). FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics. Journal of Controlled Release. 382. 113678–113678. 9 indexed citations
2.
Yang, Tao, Jingyu Sun, Hong Wang, et al.. (2025). 18 F-/ 68 Ga-Labeled Peptide-Based Probes for PET Imaging of ROR1 Expression. Journal of Medicinal Chemistry. 68(24). 26049–26060.
3.
Meng, L., Jingru Zhang, Huifeng Li, et al.. (2025). Modification of Asp–Peptide Adapters: Giving the FAP-Targeted Radioligand a “Squirrel Tail”. Journal of Medicinal Chemistry. 68(6). 6576–6587. 3 indexed citations
4.
Meng, Lingxin, Jianyang Fang, Jingru Zhang, et al.. (2024). Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types. Journal of Medicinal Chemistry. 67(10). 8460–8472. 11 indexed citations
5.
Zeng, Xinying, Jia Liu, Xuejun Wen, et al.. (2024). Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics. European Journal of Nuclear Medicine and Molecular Imaging. 51(6). 1582–1592. 11 indexed citations
6.
Chen, Xuedong, Dongsheng Xia, L. Meng, et al.. (2024). Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers. Journal of Medicinal Chemistry. 67(10). 8361–8371. 9 indexed citations
7.
Fang, Jianyang, Xiaobo Wang, Lingxin Meng, et al.. (2024). Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging. ACS Pharmacology & Translational Science. 7(6). 1783–1794. 3 indexed citations
8.
Liu, Hongwu, Yike Wang, Xuedong Chen, et al.. (2024). Development of Preladenant-Based Radiotracers for Imaging A2AR in Tumors. Journal of Medicinal Chemistry. 67(15). 13056–13066. 1 indexed citations
9.
Zang, Jie, Xuejun Wen, Chao Wang, et al.. (2023). A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers. Clinical Nuclear Medicine. 48(10). 861–868. 11 indexed citations
10.
Wen, Xuejun, Jia Liu, Xinying Zeng, et al.. (2023). In Vivo Comparative Study of Radioiodinated Folate Receptor Targeting Albumin Probes for Atherosclerosis Plaque Imaging. Bioconjugate Chemistry. 34(12). 2387–2397. 5 indexed citations
11.
Wen, Xuejun, Xinying Zeng, Changrong Shi, et al.. (2022). Optimum Combination of Radiopharmaceuticals‐Based Targeting‐Triggering‐Therapy Effect and PD‐L1 Blockade Immunotherapy. Advanced Therapeutics. 6(3). 6 indexed citations
12.
Wen, Xuejun, et al.. (2022). Novel Radiolabeled TMTP1 for Long-Acting Hepatocellular Carcinoma Therapeutics. Molecular Pharmaceutics. 19(9). 3178–3186. 4 indexed citations
13.
Wen, Xuejun, Xinying Zeng, Jia Liu, et al.. (2022). Synergism of 64Cu-Labeled RGD with Anti-PD-L1 Immunotherapy for the Long-Acting Antitumor Effect. Bioconjugate Chemistry. 33(11). 2170–2179. 9 indexed citations
14.
Shi, Changrong, Qianyu Zhang, Yuying Yao, et al.. (2022). Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics. Nature Nanotechnology. 18(1). 86–97. 78 indexed citations
15.
Li, Jindian, Yingxi Chen, Huanhuan Liu, et al.. (2022). Micro-SPECT Imaging of Acute Ischemic Stroke with Radioiodinated Riboflavin in Rat MCAO Models via Riboflavin Transporter Targeting. ACS Chemical Neuroscience. 13(13). 1966–1973. 10 indexed citations
16.
Wen, Xuejun, Changrong Shi, Yang Liu, et al.. (2021). A radioiodinated FR-β-targeted tracer with improved pharmacokinetics through modification with an albumin binder for imaging of macrophages in AS and NAFL. European Journal of Nuclear Medicine and Molecular Imaging. 49(2). 503–516. 17 indexed citations
17.
Xu, Duo, Xinying Zeng, Xuejun Wen, et al.. (2021). Radioiodinated 4-(p-Iodophenyl) Butanoic Acid-Modified Estradiol Derivative for ER Targeting SPECT Imaging. Analytical Chemistry. 93(41). 13998–14006. 13 indexed citations
18.
Zhao, Liang, Haojun Chen, Zhide Guo, et al.. (2020). Targeted Radionuclide Therapy in Patient-Derived Xenografts Using 177Lu-EB-RGD. Molecular Cancer Therapeutics. 19(10). 2034–2043. 24 indexed citations
19.
Wang, Tingting, Wentao Dong, Qiang Wang, et al.. (2020). Preclinical Evaluation of a Novel 99mTc-Labeled CB86 for Rheumatoid Arthritis Imaging. ACS Omega. 5(49). 31657–31664. 3 indexed citations
20.
Wen, Xuejun, Changrong Shi, Duo Xu, et al.. (2019). Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography. Molecular Pharmaceutics. 16(2). 816–824. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wiltrud Lederle Breakdown of academic impact, for papers by Zhanhong Wu Breakdown of academic impact, for papers by Christopher G. England Breakdown of academic impact, for papers by Sophie Hernot Breakdown of academic impact, for papers by Vasileios Askoxylakis Breakdown of academic impact, for papers by Reinier Hernandez Breakdown of academic impact, for papers by Daniel L.J. Thorek Breakdown of academic impact, for papers by Jason M. Warram Breakdown of academic impact, for papers by Emily B. Ehlerding Breakdown of academic impact, for papers by Aron Popovtzer
Rankless by CCL
2026